In addition, HDAC inhibitors are acknowledged as effective anti-inflammatory agents, some inhibiting NF-κB (19–21) and may therefore play an important role in the prevention of cancers that develop as a result of chronic inflammation. This evidence concerns the gene NFKB1 and cancer.